Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 4,857 | 3,620 | 4,094 | 4,115 | 4,349 |
| Operating Income | -4,857 | -3,620 | -4,094 | -4,115 | -4,349 |
| Interest Expense | 232 | 283 | 287 | 325 | 364 |
| Other Income | 2 | -52 | -5 | 181 | -36 |
| Pre-tax Income | -5,086 | -3,955 | -4,385 | -4,259 | -4,748 |
| Net Income Continuous | -5,086 | -3,955 | -4,385 | -4,259 | -4,748 |
| Net Income | $-5,086 | $-3,955 | $-4,385 | $-4,259 | $-4,748 |
| EPS Basic Total Ops | -0.18 | -0.24 | -0.59 | -0.57 | -0.66 |
| EPS Basic Continuous Ops | -0.18 | -0.25 | -0.59 | -0.57 | -0.66 |
| EPS Diluted Total Ops | -0.18 | -0.24 | -0.59 | -0.57 | -0.66 |
| EPS Diluted Continuous Ops | -0.18 | -0.25 | -0.59 | -0.57 | -0.66 |
| EBITDA(a) | $-4,715 | $-3,448 | $-3,913 | $-3,914 | $-4,139 |